Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase...

Area of Science:

• Oncology
• Molecular Biology
• Diagnostics

Background:

• Prostate cancer (PC) detection and monitoring are crucial for patient management.
• Circulating tumor cells (CTCs) in peripheral blood (PB) are potential biomarkers.
• Sensitive and specific methods for CTC detection are needed.

Purpose of the Study:

• To develop and assess a novel three-step immunobead reverse transcriptase (RT) polymerase chain reaction (PCR) assay for detecting circulating prostate cancer cells.
• To evaluate the assay's sensitivity, specificity, and correlation with disease progression and serum prostate-specific antigen (PSA) levels.

Main Methods:

• A three-step immunobead RT-PCR assay targeting prostatic specific membrane antigen (PSMA) messenger RNA (mRNA) was developed.
• Peripheral blood samples from prostate cancer patients and healthy controls were analyzed.
• Magnetic beads coated with Ber-EP4 antibody enriched epithelial cells, followed by mRNA isolation and nested RT-PCR for PSMA.

Main Results:

• The assay detected one PC cell per 1 mL of PB, demonstrating high sensitivity.
• RT-PCR positivity was significantly higher in patients with metastatic disease (44%) versus non-metastatic disease (5%).
• Positivity strongly correlated with progressive metastatic disease (77%) and elevated serum PSA levels (P = 0.005).

Conclusions:

• The three-step immunobead PSMA RT-PCR assay is a sensitive and specific method for detecting circulating prostate cancer cells.
• Assay positivity correlates with advanced metastatic disease and high PSA levels, suggesting its potential as a prognostic marker.